Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists

Detalles Bibliográficos
Autores principales: Meynaar, Iwan A., van Rijn, Simone, Ottens, Thomas H., van Burgel, Nathalie D., van Nieuwkoop, Cees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171741/
https://www.ncbi.nlm.nih.gov/pubmed/35670819
http://dx.doi.org/10.1007/s00134-022-06750-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171741/
https://www.ncbi.nlm.nih.gov/pubmed/35670819
http://dx.doi.org/10.1007/s00134-022-06750-w

Ejemplares similares